AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research.
Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input.
To remediate this issue, users should upgrade to version 0.0.36 or later.
0.4%(unchanged from 0.4% a week ago; 0.4% 30 days ago) estimated probability of exploitation activity in the next 30 days; 29th percentile. Scored 2026-11-16. A forecast for this CVE across the internet, not for your own systems.
CISA's assessment (SSVC)
Exploitation: none · Automatable: no · Technical impact: partial, assessed 2026-07-20. From CISA's Vulnrichment in the CVE List: whether it is exploited, whether exploiting it can be automated, and how much control it gives.
Show the promptExplain CVE-2026-15415 for an engineer deciding whether to act. Use https://cve.bz/api/public/cves/CVE-2026-15415?via=ask-ai-copy and https://cve.bz/cve/CVE-2026-15415?via=ask-ai-copy as the source of truth: what is affected and which versions fix it, whether it is in CISA KEV, public exploits, and its EPSS (an internet-wide 30-day estimate of exploitation activity, not a forecast for my systems). If they give no fixed versions, use the CVE record https://cveawg.mitre.org/api/cve/CVE-2026-15415 or the vendor advisory, not third-party mirrors. Tell me how to check whether I am affected and how to verify a fix. Cite the sources and say where they are uncertain.
Opens a third-party assistant; its answer is its own, not cve.bz's. The prompt holds only this CVE's id and public links.